NCT02877498

Brief Summary

Neuroparalytic snake envenomation results in severe muscle weakness and respiratory failure. Treatment requires administration of anti-snake venom and supportive care in the form of invasive mechanical ventilation. Whether using adaptive support ventilation (a closed loop mode of ventilation) in comparison to volume controlled ventilation will shorten the duration of ventilation remains undetermined. The current study is planned to compare adaptive support ventilation (ASV) mode of ventilation versus volume controlled ventilation (VCV) during invasive mechanical ventilation for the management of respiratory failure secondary to neuroparalytic snake envenomation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

April 20, 2022

Status Verified

April 1, 2022

Enrollment Period

3.2 years

First QC Date

August 17, 2016

Last Update Submit

April 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Liberation from mechanical ventilation

    Liberation from mechanical ventilation (defined as time \[in hours\] between intubation to extubation for at least six hours)

    28 days after discharge

Secondary Outcomes (4)

  • Incidence of ventilator associated pneumonia

    28 days after discharge

  • Post extubation respiratory failure

    28 days after discharge

  • In hospital mortality

    28 days after discharge

  • ICU and hospital length of stay

    28 days after discharge

Study Arms (2)

Adaptive support ventilation

EXPERIMENTAL

adaptive support ventilation mode during invasive mechanical ventilation

Other: Adaptive support ventilation

Volume controlled ventilation

ACTIVE COMPARATOR

Volume controlled ventilation during invasive mechanical ventilation

Other: Volume controlled ventilation

Interventions

Adaptive support ventilation during invasive mechanical ventilation

Adaptive support ventilation

Volume controlled ventilation during invasive mechanical ventilation

Volume controlled ventilation

Eligibility Criteria

Age12 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Need for invasive mechanical ventilation for management of respiratory failure
  • age group of 12 to 90 years
  • ability to provide informed consent to participate in the study

You may not qualify if:

  • Cardiorespiratory arrest requiring cardiopulmonary resuscitation
  • pregnancy
  • failure to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory ICU, Post Graduate Institue of Medical Education and Research

Chandigarh, 160012, India

Location

MeSH Terms

Conditions

Snake Bites

Condition Hierarchy (Ancestors)

Bites and StingsPoisoningChemically-Induced DisordersWounds and Injuries

Study Officials

  • Ritesh Agarwal, MD,DM

    PGIMER,Chandigarh

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Pulmonary Medicine

Study Record Dates

First Submitted

August 17, 2016

First Posted

August 24, 2016

Study Start

December 1, 2016

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

April 20, 2022

Record last verified: 2022-04

Locations